These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Simplification and improvement of height-based azithromycin treatment for paediatric trachoma. Basilion EV; Kilima PM; Mecaskey JW Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):6-12. PubMed ID: 15550255 [TBL] [Abstract][Full Text] [Related]
43. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection. Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ; Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703 [TBL] [Abstract][Full Text] [Related]
44. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison. Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542 [TBL] [Abstract][Full Text] [Related]
45. Oral use of azithromycin for the treatment of acne rosacea. Fernandez-Obregon A Arch Dermatol; 2004 Apr; 140(4):489-90. PubMed ID: 15096385 [No Abstract] [Full Text] [Related]
47. Efficacy of azithromycin administration in prevention of respiratory tract infection after bronchoscopic biopsy: a randomized, controlled trial. Kanazawa H Respirology; 2007 Jan; 12(1):70-5. PubMed ID: 17207028 [TBL] [Abstract][Full Text] [Related]
48. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections. Sader HS; Jones RN Expert Rev Anti Infect Ther; 2007 Feb; 5(1):29-43. PubMed ID: 17266451 [TBL] [Abstract][Full Text] [Related]
49. Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections. Powers JL Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S30-7. PubMed ID: 8878244 [TBL] [Abstract][Full Text] [Related]
50. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis. Temple AR; Benson GD; Zinsenheim JR; Schweinle JE Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643 [TBL] [Abstract][Full Text] [Related]
51. Leflunomide: a manageable safety profile. van Riel PL; Smolen JS; Emery P; Kalden JR; Dougados M; Strand CV; Breedveld FC J Rheumatol Suppl; 2004 Jun; 71():21-4. PubMed ID: 15170904 [TBL] [Abstract][Full Text] [Related]
52. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections. Ioannidis JP; Contopoulos-Ioannidis DG; Chew P; Lau J J Antimicrob Chemother; 2001 Nov; 48(5):677-89. PubMed ID: 11679557 [TBL] [Abstract][Full Text] [Related]
53. Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study. Rheingold SR; Hogarty MD; Blaney SM; Zwiebel JA; Sauk-Schubert C; Chandula R; Krailo MD; Adamson PC; J Clin Oncol; 2007 Apr; 25(12):1512-8. PubMed ID: 17442993 [TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis. Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096 [TBL] [Abstract][Full Text] [Related]
55. Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content. Manlhiot C; Tyrrell PN; Liang L; Atkinson AR; Lau W; Feldman BM Pediatrics; 2008 Mar; 121(3):e626-30. PubMed ID: 18299304 [TBL] [Abstract][Full Text] [Related]
56. Comparative evaluation of 2 g single dose versus conventional dose azithromycin in uncomplicated skin and skin structure infections. Dey SK; Das AK; Sen S; Hazra A Indian J Pharmacol; 2015; 47(4):365-9. PubMed ID: 26288467 [TBL] [Abstract][Full Text] [Related]
57. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial. Marple BF; Roberts CS; de Caprariis PJ; Reisman A Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585 [TBL] [Abstract][Full Text] [Related]
58. Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects. Saez-Llorens X; Violari A; Ndiweni D; Yogev R; Cashat M; Wiznia A; Chittick G; Harris J; Hinkle J; Blum MR; Adda N; Rousseau F; Pediatrics; 2008 Apr; 121(4):e827-35. PubMed ID: 18332076 [TBL] [Abstract][Full Text] [Related]
59. Multicenter randomized study of two once daily regimens in the initial management of community-acquired respiratory tract infections in 163 children: azithromycin versus ceftibuten. Galova K; Sufliarska S; Kukova Z; Danisovicova A; Hrachova I; Grausova S; Marinova I; Krizan S; Stopkova K; Stahorska A; Durcanska K; Raskova J; Krupova I; Krcméry V Chemotherapy; 1996; 42(3):231-4. PubMed ID: 8983893 [TBL] [Abstract][Full Text] [Related]
60. [Azithromycin for pediatric indications. Brief therapy is ideal for children]. MMW Fortschr Med; 2002 Nov; 144(47):61. PubMed ID: 12532527 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]